Microbiota-derived short-chain fatty acids (SCFA) modulate stroke recovery. The effect was mediated by circulating lymphocytes on microglia activation. The study reports SCFAs could be a potential therapeutic to improve post-stroke recovery.
Researchers have developed a probiotic 'cocktail' from gut bacteria found in infant feces. They say the 'cocktail' could help to increase the body's ability to produce short chain fatty acids. The probiotic could be used to help those suffering from cancers, autoimmune disorders, obesity, diabetes and other disorders which limit the ability of the body to produce SCFAs naturally.